Kairos Pharma, LTD 8-K filings

AMEX

17 Sept 2024

KAPA

8-K: Kairos Pharma Closes $6.2 Million Initial Public Offering

Kairos Pharma, a clinical-stage biopharmaceutical company, has successfully completed its initial public offering, raising $6.2 million before expenses.